bcl-2 Immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia

Modern Pathology

Volumn 12, Issue 6, 1999, Pages 612-617

  Cooper, Kum ^a,b   Haffajee, Zenobia ^a   Taylor, Louise ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Bcl 2; Cervical intraepithelial neoplasia; Human papillomavirus

Indexed keywords

BIOTIN; HORSERADISH PEROXIDASE; PROTEIN BCL 2; STREPTAVIDIN; VIRUS DNA;

ARTICLE; CARCINOMA IN SITU; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; VIRUS DETECTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; SOUTH AFRICA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033037212     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. H on chromosome 14 near a transcriptional unit on chromosome 18. Cell 1985;41:899-906.
2. Pezzella F, Ralfkiaer E, Gatter KC, Mason DY. The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction. Br J Haematol 1990;76:58-64.
3. Cooper K, Haffajee Z. bcl-2 immunohistochemistry distinguishes follicular lymphoma from follicular hyperplasia in formalin-fixed tissue with microwave antigen retrieval. J Cell Pathol 1996;1:52-6.
4. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
5. Herrington CS. HPV and cervical neoplasia. I. Classification, virology, pathology, and epidemiology. J Clin Pathol 1994; 47:1066-72.
6. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of HPV in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
7. Sherman ME, Schiffman MH, Lörincz AT, Manos MM, Scott DR, Kuman RJ, et al. Towards objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk HPV types. Am J Clin Pathol 1994;102:182-7.
8. Herrington CS. HPV and cervical neoplasia. II. Interaction of HPV with other factors. J Clin Pathol 1995;48:1-6.
9. Ter Harmsel BT, Smedts F, Kuijpers J, Jeunink M, Trimbos B, Ramaekers F. bcl-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol 1996;179:26-30.
10. Saegusa M, Takano Y, Hashimura M, Shoji Y, Okayasu I. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 1995;76:2297-303.
11. Kurvinen K, Syrjänen K, Syrjänen S. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. J Clin Oncol 1996;14:2120-30.
12. Nakamura T, Nomura S, Sakai T, Nariya S. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions. Hum Pathol 1997;28: 309-15.
13. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo. J Clin Pathol 1991;44:400-5.
14. Cooper K, Herrington CS, Strickland JE, Evans MF, McGee JO'D. Episomal and integrated HPV in cervical neoplasia shown by nonisotopic in situ hybridization. J Clin Pathol 1991;44:990-6.
15. Vooijs GP. Benign proliferative reactions, intraepithelial neoplasia, and invasive cancer of the uterine cervix. In: Bibbo B, editor. Comprehensive cytopathology. Philadelphia: Saunders; 1991. p. 153-230.